BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24965108)

  • 21. Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.
    Lee S; Park HY; Kang SY; Kim SJ; Hwang J; Lee S; Kwak SH; Park KS; Yoo HY; Kim WS; Kim JI; Ko YH
    Oncotarget; 2015 Jul; 6(19):17764-76. PubMed ID: 25980440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
    Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in multiple omics of natural-killer/T cell lymphoma.
    Xiong J; Zhao WL
    J Hematol Oncol; 2018 Dec; 11(1):134. PubMed ID: 30514323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extranodal natural killer/T-Cell lymphoma: A population-based comparison of sinonasal and extranasal disease.
    Vazquez A; Khan MN; Blake DM; Sanghvi S; Baredes S; Eloy JA
    Laryngoscope; 2014 Apr; 124(4):888-95. PubMed ID: 24114591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
    de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
    J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic and molecular features of 122 Brazilian cases of nodal and extranodal NK/T-cell lymphoma, nasal type, with EBV subtyping analysis.
    Gualco G; Domeny-Duarte P; Chioato L; Barber G; Natkunam Y; Bacchi CE
    Am J Surg Pathol; 2011 Aug; 35(8):1195-203. PubMed ID: 21716086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
    Zhang S; Li T; Zhang B; Nong L; Aozasa K
    Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of T-cell receptor signalling pathway components in extranodal NK/T-cell lymphoma.
    Miyata-Takata T; Chuang SS; Takata K; Toji T; Maeda Y; Sato Y; Yoshino T
    Histopathology; 2018 Dec; 73(6):1030-1038. PubMed ID: 30102799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
    Bergmann AK; Schneppenheim S; Seifert M; Betts MJ; Haake A; Lopez C; Maria Murga Penas E; Vater I; Jayne S; Dyer MJ; Schrappe M; Dührsen U; Ammerpohl O; Russell RB; Küppers R; Dürig J; Siebert R
    Genes Chromosomes Cancer; 2014 Apr; 53(4):309-16. PubMed ID: 24446122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK3 in clear cell renal cell carcinoma: mutational screening and clinical implications.
    de Martino M; Gigante M; Cormio L; Prattichizzo C; Cavalcanti E; Gigante M; Ariano V; Netti GS; Montemurno E; Mancini V; Battaglia M; Gesualdo L; Carrieri G; Ranieri E
    Urol Oncol; 2013 Aug; 31(6):930-7. PubMed ID: 21868263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutant JAK3 signaling is increased by loss of wild-type JAK3 or by acquisition of secondary JAK3 mutations in T-ALL.
    Degryse S; Bornschein S; de Bock CE; Leroy E; Vanden Bempt M; Demeyer S; Jacobs K; Geerdens E; Gielen O; Soulier J; Harrison CJ; Constantinescu SN; Cools J
    Blood; 2018 Jan; 131(4):421-425. PubMed ID: 29187379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A unique case of adolescent CD56-negative extranodal NK/T-cell lymphoma, nasal type.
    Chang BH; Stork L; Fan G
    Pediatr Dev Pathol; 2008; 11(1):50-4. PubMed ID: 18237230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma.
    Kameda T; Shide K; Shimoda HK; Hidaka T; Kubuki Y; Katayose K; Taniguchi Y; Sekine M; Kamiunntenn A; Maeda K; Nagata K; Matsunaga T; Shimoda K
    Int J Hematol; 2010 Sep; 92(2):320-5. PubMed ID: 20697856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of tofacitinib to achieve an objective response in a
    Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
    Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-kit Expression and mutations in peripheral T cell lymphomas, except for extra-nodal NK/T cell lymphomas.
    Choe YS; Kim JG; Sohn SK; Kim DH; Baek JH; Lee KB; Do YR; Kwon KY; Song HS; Lee MH; Park TI
    Leuk Lymphoma; 2006 Feb; 47(2):267-70. PubMed ID: 16321856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.